Biogen Inc (BIIB) Stock: Should Investors Follow These Insider Trades?
Biogen Inc (NASDAQ:BIIB) saw a downside of -0.48% to close Friday at $257.68 after subtracting -$1.25 on the day. The 5-day average trading volume is 799,020 shares of the company’s common stock. It has gained $262.48 in the past week and touched a new high 3 times within the past 5 days. An average of […]
Biogen Inc. (BIIB): What Does Valuation Ratios Tell Us?
Biogen Inc. (NASDAQ:BIIB) saw a downside of -0.13% to close Friday at $261.15 after subtracting -$0.35 on the day. The 5-day average trading volume is 690,340 shares of the company’s common stock. It has gained $274.05 in the past week and touched a new high 1 time within the past 5 days. An average of […]
What Can We Learn From Biogen Inc. (BIIB)’s Valuation Ratios?
Biogen Inc. (NASDAQ:BIIB) finished Friday with an addition of $4.62 to close at $273.68, an upside of 1.72 percent. An average of 1,019,020 shares of common stock have been traded in the last five days. There was a gain of $4.76 in the past week, and it reached a new high 19 times over the […]
